CAS RN: 2244-60-2
10,11-DIHYDRO-DIBENZO[B,F][1,4]OXAZEPINE
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250614
100mg / 1g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 2244-60-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Hong Kong
Inquiry
2244-60-2 / 5,6-dihydrobenzo[b][1,4]benzoxazepine
Standard CAS: 2244-60-2
Multi CAS: No
Basic Information
copy
CAS
2244-60-2 copy
Multi CAS
No copy
Molecular Formula
C13H11NO copy
Molecular Weight
197.230000 copy
Exact Mass
197.084064 copy
SMILES
C1C2=CC=CC=C2OC3=CC=CC=C3N1 copy
InChI
InChI=1S/C13H11NO/c1-3-7-12-10(5-1)9-14-11-6-2-4-8-13(11)15-12/h1-8,14H,9H2 copy
InChIKey
YUFONPPSLOZSAT-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
15 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.08 copy
H-bond acceptors
2 copy
H-bond donors
1 copy
Molar refractivity
60.28 copy
TPSA
21.26 copy
LogP / Solubility
WLOGP
3.4 copy
MLOGP
3 copy
XLogP3
3 copy
Consensus LogP
3.13 copy
Log S (ESOL)
-3.8 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.64 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.77 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.51 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy